US Patent

US10441630 — Topical formulations and uses thereof

Formulation · Assigned to Sun Pharma Global FZE · Expires 2033-08-23 · 7y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects topical formulations, including ophthalmic formulations, for treating or preventing diseases or conditions.

USPTO Abstract

Provided herein include formulations for topical administration, such as ophthalmic formulations, and methods of using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and or a polyalkoxylated alcohol and may include nanomicelles. Also include methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.

Drugs covered by this patent

Patent Metadata

Patent number
US10441630
Jurisdiction
US
Classification
Formulation
Expires
2033-08-23
Drug substance claim
No
Drug product claim
Yes
Assignee
Sun Pharma Global FZE
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.